Perioperative beta-Adrenergic Blocker and a COX2 Inhibitor in Patients Undergoing Resection for Primary Colon and Rectal Cancer: Effect on Tumor Recurrence and Postoperative Immune Perturbations. A Multicenter Randomized Prospective Trial.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Etodolac; Propranolol
- Indications Colorectal cancer
- Focus Therapeutic Use
Most Recent Events
- 12 Jul 2011 Biomarkers information updated
- 27 Feb 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 05 May 2009 New trial record